PARATUS acquires projodis

PARATUS expands its LIS offering, acquiring projodis, Germany’s leading provider of laboratory software solutions in human genetics

Munich, Germany, September 9, 2024. GREENPEAK Partners announced today that through their group PARATUS, they have acquired projodis, the leading provider of laboratory information system (LIS) solutions servicing human geneticists in Germany with further presence in Austria and Switzerland. The acquisition is another strategic building block for PARATUS in its mission to become a leading global provider of best-of-breed healthcare IT solutions, focussing on diagnostics, that empower medical service professionals and improve patient care.

The decision to acquire projodis was influenced by their strong market position in human genetics and strategic fit within PARATUS’ growing group. “The projodis product portfolio is a perfect complement to that of DB Soft, our LIS provider in Spain,” said Friedrich von Kleist, CEO of PARATUS.

“Adding them to our group and aligning them with DB Soft enables us to build a strong LIS Cluster, which significantly advances our LIS technology and portfolio and supports the expansion into new markets while strengthening the whole PARATUS group.”

In line with PARATUS’ business strategy, projodis will retain its individual operations and brand identity, emphasizing PARATUS’ commitment to collaboration without losing the renowned market presence of its acquired companies. projodis products and services will continue without disruption in access or customer support.

“I’m thrilled we’ve found a strong partner to take the next step in our company’s development,” said Oliver Krause, Founder and Managing Director of projodis. “A driving factor in our decision to join the group was having, through prior work, already experienced the truly collaborative culture of PARATUS.” Krause added, “I’m confident that together we can grow faster, accelerate innovation, and deliver even better services to our clients.”

PARATUS’ robust support for its group companies encompasses financial investment, collaborative tendering, and access to shared resources in areas such as finance, marketing, sales, quality management, new market entry, and more.

Media Contact

For more information or to schedule an interview, please contact:

Mr. Friedrich von Kleist, CEO of PARATUS
fkleist@paratus-group.com

About PARATUS:

PARATUS was formed in 2021 with the goal of creating a global group of best-of-breed healthcare IT companies with a strong position in diagnostics that collaborates to deliver state-of-the-art, tailored solutions to medical service providers that improve healthcare services and patient care, boost productivity, and reduce costs. PARATUS is a group of like-minded market leaders that foster growth through collaboration, sharing best practices, and shared services in finance, HR, regulatory, IT security, and more. Headquartered in Munich, Germany, PARATUS is pursuing a long-term growth path, both organically and by adding new partners to its group. Learn more at www.paratus-group.com

About projodis:

projodis GmbH is the German market leader in advanced laboratory software solutions, specializing in the development and implementation of cutting-edge tools for the management, control, and monitoring of human genetic laboratory processes and consultations. Based in Butzbach, Germany, and founded in 2010, projodis serves the majority of the human genetic departments of university hospitals and leading outpatient genetic laboratories due to a clear focus and understanding of the unique needs of the genetic field. www.projodis.net

About GREENPEAK Partners:

GREENPEAK Partners is a company builder with a proven track record and comprehensive expertise in the foundation, development, and expansion of industry leaders. While executing its Buy & Build strategies, GREENPEAK aims to develop industry leaders by virtue of strong partnerships, ESG values, and aligned sustainable interests. To date, the GREENPEAK Partners team has built over ten platforms, with annual revenues exceeding €1 billion. www.greenpeak-partners.com

ALPHALYTIK JOINS CERTANIA GROUP

The specialist in pharmaceutical analytical testing becomes part of the CERTANIA family.

Berlin/Munich, Sept. 4, 2024—Alphalytik Pharmaservice GmbH, a leading expert in pharmaceutical analytical testing, proudly announces its integration into CERTANIA, a dynamic group specializing in Testing, Inspection, and Certification services. This strategic move marks a significant milestone for Alphalytik, enhancing its capabilities to deliver specialized stability testing and method validation services to a broader range of pharmaceutical clients.

Founded in 1995 and headquartered in Berlin, Germany, Alphalytik has built a strong reputation as an independent laboratory specializing in GMP (Good Manufacturing Practice) and FDA (Food and Drug Administration) approved stability testing, method development, and release testing. With a focus on complex drug formulations, including low-dose and hormone preparations, Alphalytik serves a diverse clientele, including some of the world’s leading pharmaceutical companies.

The company’s expertise in ensuring the long-term safety and efficacy of pharmaceutical products has made it a trusted partner.

By joining CERTANIA, Alphalytik gains access to a powerful platform that will allow it to expand its service offerings and strengthen its position in the pharmaceutical market. This partnership will enable Alphalytik to address the growing demand for specialized pharmaceutical testing services, driven by increasing drug development and regulatory requirements.

Dr. Nicolas Schauer has been appointed as the new managing director and Dr. Richard Herzog, the founder of Alphalytik, will continue to support the company in a consulting role, ensuring a seamless transition and continuity in client relationships. “We are excited to join CERTANIA, a group that shares our commitment to excellence in pharmaceutical testing,” said Dr. Richard Herzog, founder of Alphalytik. “This partnership will provide us with the resources and support needed to continue delivering high-quality, reliable services to our clients while also exploring new growth opportunities.”

Karsten Xander, CEO and founder of CERTANIA, welcomed Alphalytik to the group, emphasizing the strategic importance of the acquisition. “The addition of Alphalytik significantly strengthens CERTANIA’s position in the pharmaceutical contract research and manufacturing segment. Their expertise in stability and release testing and method validation complements our existing services, and we see great potential for synergy and growth.”

CERTANIA’s acquisition of Alphalytik underscores the group’s commitment to expanding its capabilities in the life sciences sector, enhancing its market presence in Germany and beyond. The integration is expected to drive innovation, improve service offerings, and foster significant growth within the CERTANIA group.

CERTANIA provides a platform for mid-sized, knowledge-based companies to thrive under one umbrella, maintaining entrepreneurial freedom while benefiting from group resources and support.

About Alphalytik:

Founded in 1995 and headquartered in Berlin, Germany, Alphalytik Pharmaservice GmbH is a specialized pharmaceutical laboratory offering drug stability testing, method development, and release testing. With a focus on complex analytical needs, Alphalytik serves a diverse clientele, including leading pharmaceutical companies. The company’s expertise and accredited services ensure the long-term safety and efficacy of pharmaceutical products. For more information, visit alphalytik.com.

About CERTANIA:

Under the umbrella of CERTANIA Holding GmbH, a new global market player is created in the field of Testing, Inspection & Certification as well as scientific, laboratory and compliance services. This group offers medium-sized partners a sustainable home for their life’s work. CERTANIA enables entrepreneurs and owners to further develop their companies with like-minded people, while continuing to preserve their entrepreneurial roots, corporate culture, brand, and values. For more information, visit certania.com

BIOTEC JOINS CERTANIA GROUP

The pioneer in microbiological and aerial hygiene joins the group.

Munich/Gütersloh, August 20, 2024. Biotec GmbH, a leading consultancy and environmental laboratory specializing in microbiological hygiene and occupational health, has joined CERTANIA, a dynamic group known for its Testing, Inspection, and Certification services. This strategic integration marks a pivotal moment for Biotec GmbH, enhancing its ability to expand its environmental and hygiene solutions globally.

Founded in 1991 and based in Gütersloh, Germany, Biotec GmbH has built a solid reputation over 25 years as a pioneer in aerial hygiene. Its clientele spans across industrial giants and prominent players in the food industry, relying on its expertise for comprehensive air hygiene testing and certification, drinking water analyses, and specialized hygiene training.

By joining CERTANIA, Biotec GmbH aligns itself with a robust platform that supports its commitment to excellence. The partnership strengthens Biotec GmbH’s capabilities in optimizing hygiene-sensitive production processes and validating hospital cleaning and disinfection equipment to meet stringent hygiene standards.

Under the leadership of the managing directors Dr. Andreas Bermpohl, Jörg Weißer and Frank Weißer, the Biotec management team retains independence while accessing the resources of the larger group, facilitating continued growth and service expansion. “We are thrilled to join CERTANIA, which allows us to amplify our impact in ensuring safe and compliant environments,” said Dr. Andreas Bermpohl, co-founder and managing director of Biotec GmbH. “This partnership not only enhances our service offerings but also reinforces our dedication to delivering high-quality solutions backed by rigorous scientific expertise.”

Moritz Gruber, CEO and managing shareholder of CERTANIA, welcomes Biotec and extends the invitation to join this unique group to other entrepreneurs and owners of companies in the field of scientific, laboratory, and compliance services: “We provide an opportunity to put their company into a future-proof structure. It is our fundamental aim to build a group for the long run, where strong partner companies flourish, while retaining their identity. Biotec’s renowned expertise in microbiological hygiene perfectly complements CERTANIA’s focus on environmental and regulatory services. Together, we are well-positioned to support industries in maintaining safety and compliance standards amid evolving global challenges like the COVID19 pandemic.”

CERTANIA’s ecosystem provides a platform for mid-sized, knowledge-based companies to thrive under one umbrella, maintaining entrepreneurial freedom while benefiting from group resources and support.

About Biotec GmbH:

Founded in 1991 and based in Gütersloh and Mittweida, Germany, Biotec GmbH is a leading consultancy and environmental laboratory specializing in microbiological hygiene and occupational health. With over 25 years of expertise, we pioneer aerial hygiene solutions for diverse industrial and food industry clients. Our services include air hygiene testing, HVAC system inspections under VDI 6022 standards, and hygiene training. Biotec GmbH is committed to excellence, supporting clients with high-quality services and expert opinions to maintain safe and compliant environments. For more information, visit biotec-gmbh.de

About CERTANIA:

GREENPEAK is proudly looking back to a successful first half-year 2024

We would like to thank all our business partners and our teams and look forward to a fantastic second half of the year.

MEDIATOR JOINS CERTANIA

Expert for regulatory advisory services for chemical and hazardous substance regulations joins the group.

Munich/Kolding, June 26 2024. Mediator has partnered with CERTANIA, a growing group specializing in Testing, Inspection, and Certification services. This strategic move allows Mediator, a leading provider for regulatory advisory services, focusing on chemical and hazardous substances to accelerate growth activities.

Established in 2011 and headquartered in Kolding, Denmark, Mediator has emerged as an expert and trusted partner for cosmetics, biocide, cleaning, and surface treatment industries with comprehensive regulatory support

Joining CERTANIA marks a significant milestone for Mediator, opening doors to expand internationally. This partnership enhances the company’s ability to continue to ensure safety, quality, and regulatory compliance and conformity services for customers around the world.

Under the leadership of Jens Haugaard, the Mediator management team retains independence while accessing the resources of the larger group, facilitating continued growth and service expansion. Says Jens Haugaard about the strategic move: „With the joint expertise and the collaboration with other CERTANIA partner companies, we will be able to support more customers in this fast-growing market segment. Being part of CERTANIA enables us to further invest in our service portfolio and infrastructure, providing innovative knowledge management tools. “

Mediator’s offering of comprehensive regulatory services perfectly fits into CERTANIA’S regulatory, sustainable, food & environment segment.

Karsten Xander, founder and CEO of CERTANIA, welcomes Mediator and extends the invitation to join this unique group to other entrepreneurs and owners of companies in the field of scientific, laboratory, and compliance services: “We provide an opportunity to put their company into a future-proof structure. It is our fundamental aim to build a group for the long run, where strong partner companies flourish, while retaining their identity. With the addition of Mediator, we can now provide more comprehensive regulatory services to customers in the cosmetic, chemical, food and environment segment”.

About Mediator:

Mediator, a Danish legal advisory service provider, specializes in regulatory compliance for chemicals and hazardous substances, focusing on industries like cosmetics, chemicals, and the environment. We offer comprehensive services, including subscription models for legislative insights, with REACH as a major regulatory driver. Mediator is distinguished by its ability to manage legal changes and provide continuous updates, aiding clients in navigating regulatory complexities. Our expertise ensures industry-specific compliance, facilitating successful product launches and enhancing client operations. For more information, visit mediator.as.

About CERTANIA: Under the umbrella of CERTANIA Holding GmbH, a new global market player is created in the field of Testing, Inspection & Certification as well as scientific, laboratory and compliance services. This group offers medium-sized partners a sustainable home for their life’s work. CERTANIA enables entrepreneurs and owners to further develop their companies with like-minded people, while continuing to preserve their entrepreneurial roots, corporate culture, brand, and values. For more information, visit certania.com

TAZ JOINS CERTANIA FOR ACCELERATED GROWTH

The leading expert in industrial testing and optical emission testing joins the group.

Munich/Aichach, May 22, 2024. TAZ GmbH, a leading industrial testing provider specializing in materials testing, proudly announces its partnership with CERTANIA, a dynamic group specializing in Testing, Inspection, and Certification services. This strategic move marks a significant milestone for TAZ GmbH, enhancing its capabilities and accelerating growth activities and strengthen the offering in this segment for CERTANIA.

Established in 1995 and headquartered in Aichach, Germany, TAZ GmbH has emerged as a trusted expert in materials testing, offering a wide range of services including mechanical, chemical, and structural testing. With accreditation in accordance with DIN EN ISO/IEC 17025, TAZ GmbH holds a prominent position in the industry. Furthermore, TAZ is the world’s first accredited calibration laboratory for spark spectrometers according to DIN EN ISO 17025, with plans to expand accreditation to include reference material production according to DIN EN ISO 17034.

Under the leadership of CEO Sebastian Mirthes and company founder and authorized representative Thomas Asam, TAZ GmbH will maintain its independence while at the same time the same time draw on the resources and support of the Certania Group. Says Thomas Asam about the strategic move: „With the joint expertise and the collaboration with other CERTANIA partner companies, we will be able to support more customers in our fast-growing market segment. Being part of CERTANIA enables us to further invest in our service portfolio and infrastructure, providing innovative knowledge management tools. “

The acquisition of TAZ GmbH complements CERTANIA’s material testing cluster, enhancing its expertise in metallography, detailed fracture assessments, and damage case analyses. With a diversified client base including prominent companies in the automotive, aviation, traffic engineering and medical industry brings valuable experience and a strong reputation for service excellence to the CERTANIA group.

Moritz Gruber, CEO and managing shareholder of CERTANIA, welcomes TAZ and extends the invitation to join this unique group to other entrepreneurs and owners of companies in the field of scientific, laboratory, and compliance services: “We provide an opportunity to put their company into a future-proof structure. It is our fundamental aim to build a group for the long run, where strong partner companies flourish, while retaining their identity. With the addition of TAZ, our combined expertise in the materials and structures segment is a force in the marketplace.”

About TAZ:

TAZ GmbH, headquartered in Aichach, Germany, is a leading provider of industrial testing services since 1995. Specializing in materials testing for industries such as automotive, aviation, traffic engineering, and medical, TAZ offers accredited mechanical, chemical, and structural analyses. Accredited as the world’s first calibration laboratory for spark spectrometers, TAZ prioritizes excellence and sustainability in its services. With a diverse client base across various industries, TAZ remains committed to driving scientific innovation and ensuring the safety and reliability of materials and products. For more information, visit tazgmbh.de

About CERTANIA:

SPINESERV JOINS CERTANIA GROUP

The expert in mechanical testing and engineering services for medical devices joins the group.

Munich/Ulm, May 8, 2024 – SpineServ GmbH & Co KG has partnered with CERTANIA, a growing group specializing in testing, inspection, and certification services. This strategic move allows SpineServ, a leading provider for mechanical testing and engineering services for medical devices, to accelerate their growth activities.

Established in 2007 and headquartered in Ulm, Germany, SpineServ has emerged as an expert and trusted partner in various industries for spinal implants, endoprostheses, trauma implants, dental implants, and other medical devices such as connectors, syringes, injection devices and catheters. The company’s core competencies lie in offering accredited and self-developed mechanical testing and engineering services, ensuring quality, safety, reliability, and innovation to its clientele.

SpineServ achieved its first accreditation as a testing laboratory in accordance with DIN EN ISO/IEC 17025 in 2008. Continuous renewal and extension of the scope of DAkkS accredited testing procedures for an increasing variety of medical devices solidified its commitment to excellence and compliance with international standards.

Joining CERTANIA marks a significant milestone for SpineServ, opening doors to future services and enhancing the company’s ability to ensure safety, quality, and regulatory compliance and conformity services for its clientele worldwide.

Under the leadership of CEO Dr. Annette Kienle, the SpineServ management team retains independence while accessing the resources of the larger group, facilitating continued growth and service expansion. “With the joint expertise from the entire CERTANIA partner community, we will become an even stronger partner for existing customers and fuel our growth plans to satisfy the growing requirements for implant safety and, thus, patient satisfaction.”

SpineServ Co-Founder Prof. Dr. Hans-Joachim Wilke expresses, “We are delighted that SpineServ is taking the next step into a promising future by partnering with CERTANIA to offer even more services of the highest quality in the field of medical device testing.”

SpineServ’s offering of accredited medical device testing services perfectly fits into CERTANIA’s segment. Moritz Gruber, CEO and managing shareholder of CERTANIA, welcomes SpineServ and extends the invitation to join this unique group to other entrepreneurs and owners of companies in the field of scientific, laboratory, and compliance services: “We provide an opportunity to put their company into a future-proof structure. It is our fundamental aim to build a group for the long run, where strong partner companies flourish, while retaining their identity. With the addition of SpineServ, we are strengthening our services in the life science segment.”

About SpineServ:

SpineServ GmbH & Co. KG, established in 2007 and headquartered in Ulm, Germany, is a leading provider of mechanical testing and engineering services for medical devices. Specializing in endoprosthesis, spine, trauma, dental, and medical device testing. SpineServ has over 16 years of experience in ensuring quality, safety, and innovation for its clientele. Accredited by DAkkS in accordance with DIN EN ISO/IEC 17025 since 2008, SpineServ is dedicated to maintaining the highest standards in the industry.
For more information, visit spineserv.de

About CERTANIA:

MPR joins CERTANIA: Paving the way for enhanced certification services

The market-leading certification expert for accessing Asian markets joins the group.

Munich/Frankfurt, April 29, 2024. MPR China Certification GmbH, a distinguished service provider and market leader of certification, conformity inspections and product tests required for accessing Asian markets, has announced its strategic partnership with CERTANIA, a rapidly growing group specializing in Testing, Inspection, and Certification (TIC) services. This collaboration marks a significant milestone for MPR, allowing the company to accelerate growth activities.

Established in 2005, MPR has garnered acclaim for its expertise in providing certification services, conformity assessment, inspections, and product testing services essential for accessing markets in China, India, Korea, and Japan.

With a strong foothold in the automotive industry and a diverse clientele spanning electronics, machinery, steel, food, and other sectors, MPR has become a trusted partner for companies seeking regulatory compliance and conformity services. This includes e.g. CCC certification for accessing the Chinese market, BIS certification for India and KC certification for Korea. MPR covers the US market with its subsidiary China Certification Corporation in Chicago.

Joining forces with CERTANIA enables MPR to accelerate its growth activities and expand its service offerings. MPR’s management team will retain independence while gaining access to the resources and support of the larger CERTANIA group.

Julian Busch, Managing Director of MPR, expressed enthusiasm about the partnership, stating, “With the joint expertise and collaboration with other CERTANIA partner companies, we will be able to support more customers in this fast-growing market segment. Being part of CERTANIA enables us to further invest in broadening our service portfolio to our clients.

Karsten Xander, CEO and Founder of CERTANIA, welcomes MPR and extends the invitation to join this unique group to other entrepreneurs and owners of companies in the field of scientific, laboratory, and compliance services: “We provide an opportunity to put their company into a future-proof structure. It is our fundamental aim to build a group for the long run, where strong partner companies flourish, while retaining their identity. With the addition of MPR, we can now strengthen our service portfolio in specialized complex certification services”.

About MPR:

MPR China Certification GmbH is a leading provider of certification, conformity assessment, inspections, and product testing services for accessing markets in China, India, Korea, and Japan. The company was founded in 2005 with a focus on automotive certification for China and has developed into the central provider for product certifications for Asia for automotive, electronics, consumer goods and food. With strategic locations and strong relationships with certification authorities, MPR offers comprehensive support tailored to client needs. Visit www.mpr-international.com/en for more information.

About CERTANIA:

GREENPEAK Partners closes inaugural Continuation Fund led by HarbourVest Partners

GREENPEAK Partners closes inaugural Continuation Fund led by HarbourVest Partners for two leading Germany-based companies in the specialty laboratories and Testing, Inspection, and Certification (‘TIC’) spaces.

MUNICH, 16th April, 2024 – GREENPEAK Partners, a leading lower mid-market focused buy and build specialist in the DACH region, is pleased to announce the successful close of GREENPEAK Continuation Fund I with total commitments of ca. EUR 350 million.

Continuation Fund I was formed to invest into ACADEMIA and CERTANIA – two strongly performing lab and TIC groups started and built up by funds managed by GREENPEAK Fund II GmbH & Co. KG (“GREENPEAK Fund II”) in 2021. Investors in Continuation Fund I will also provide additional capital to enable GREENPEAK to continue its successful growth strategies in both companies. The transaction follows GREENPEAK’s announcement of a growth capital investment in CERTANIA from Summit Partners in August 2023.

Renowned global investors support GREENPEAK’s Continuation Fund

The innovative transaction structure caters for customized exposures across one or both companies for different investors. HarbourVest Partners is acting as the Principal Lead Investor for Continuation Fund I across ACADEMIA and CERTANIA, while Kline Hill Partners is acting as the Co-Lead Investor in ACADEMIA, alongside a consortium of international syndicate investors.

As General Partner GREENPEAK is delighted to have secured backing from a top-tier group of investors, indicating the strong investor interest for high-quality companies backed by strong General Partners in the DACH region. Furthermore, Continuation Fund I constitutes an attractive liquidity offering for GREENPEAK Fund II LPs and Co-Investors, who had the option to crystallize stellar returns or continue to support the growth strategies of ACADEMIA and CERTANIA through participation in Continuation Fund I.

GREENPEAK portfolio companies with impressive organic growth and M&A track record

Under GREENPEAK’s ownership and the leadership of their respective management teams, ACADEMIA and CERTANIA have developed into leading diagnostic platforms for specialty laboratories and Testing, Inspection, and Certification (‘TIC’) services in Germany. ACADEMIA is a leading diagnostic platform focused on pathology, human genetics, hemostaseology, and prenatal diagnostics/IVF in Germany. CERTANIA is a leading provider of TIC services focused on addressing global challenges across health and sustainability, respectively. ACADEMIA and CERTANIA have built up their combined EBITDA to nearly €70 Mio., under GREENPEAK’s ownership, while completing a total of over 30 acquisitions.

Continuation Fund I will enable both companies to continue their successful investment strategy over the coming years. Management teams of both firms stay significantly invested and are committed to driving long-term success.

Daniel Beringer, Managing Partner at GREENPEAK, said: “GREENPEAK was successful in developing and supporting two outstanding companies in the testing and analytics business with ACADEMIA and CERTANIA. Together, GREENPEAK, the exceptional management teams of the groups and the joining companies, we have established the groundwork to build outstanding lab businesses, that are able to provide high quality services to their customers and be a long-term home for the entrepreneurs and employees that drive the groups. And we thank the leadership of ACADEMIA and CERTANIA for the successful work to date and look forward to continuing the journey over the coming years.”

Tim Flower, Managing Director at HarbourVest Partners, said: “We are delighted to partner up with GREENPEAK on the creation of this innovative transaction structure, which highlights the capabilities of the HarbourVest platform. Identifying and supporting strong performing General Partners in local markets managing market leading companies with outperformance potential has been an integral part of our strategy. We look forward to combining HarbourVest’s long track record of completing and managing complex transactions with GREENPEAK’s expertise to unlock the significant growth prospects of ACADEMIA and CERTANIA.”

Elena Laleh, Managing Director at Kline Hill Partners, said: “We are excited to support GREENPEAK’s continued investment in ACADEMIA through our dedicated GP-led strategy. ACADEMIA is a high-quality business with a large inorganic growth opportunity, and we are confident in GREENPEAK’s and management’s ability to continue to manage the business.

GREENPEAK was advised by PJT Park Hill (Financial Advisory), ISP Healthcare (Commercial DD), Roedl & Partner (Financial/Tax), and Stephenson Harwood, FMDH Rechtsanwälte, McDermott Will & Emery, and Orbit (Legal).

HarbourVest Partners was advised by Kirkland & Ellis on the transaction.

About GREENPEAK Partners

GREENPEAK Partners is a company builder private equity partnership with proven track record and comprehensive expertise in the foundation, development, and expansion of industry leaders. While executing its Buy & Build strategies, GREENPEAK aims to develop industry leaders by virtue of strong partnerships, ESG values, and aligned sustainable interests.

To date, the GREENPEAK Partners team has built over a dozen platforms, with annual revenues exceeding €1 billion. For more information, please see https://www.greenpeak-partners.com/de/ or Follow on Linkedin.

About HarbourVest Partners

HarbourVest is an independent, global private markets firm with over 40 years of experience and more than $125 billion of assets under management as of December 31, 2023. Our interwoven platform provides clients access to global primary funds, secondary transactions, direct co-investments, real assets and infrastructure, and private credit. Our strengths extend across strategies, enabled by our team of more than 1,150 employees, including more than 230 investment professionals across Asia, Europe, and the Americas. Across our private markets platform, our team has committed more than $59 billion to newly-formed funds, completed over $53 billion in secondary purchases, and invested over $39 billion in directly operating companies. We partner strategically and plan our offerings innovatively to provide our clients with access, insight, and global opportunities.

For further information please visit www.harbourvest.com.

About Kline Hill Partners

Founded in 2015, Kline Hill Partners is an investment firm focused on the private equity secondary market, with industry-leading capabilities in the small-deal space. With over $4 billion in assets under management, Kline Hill’s funds are backed by a blue-chip investor base that includes endowments, foundations, family offices, and other institutional investors. Together, Kline Hill’s Core and Solutions strategies make up a platform designed to serve the entirety of the small-deal secondary market, with capabilities spanning LP fund transfers, GP-led transactions, and secondary direct transactions.

For further information please visit https://klinehill.com/.

About ACADEMIA

ACADEMIA is a unique and sizeable diagnostic platform for specialty laboratory in Germany offering end-to-end diagnostic solutions supported by a successful inorganic strategy to consolidate growth. ACADEMIA is the first integrated special laboratory group focusing on pathology, human genetics, hemostaseology, and prenatal diagnostics/IVF in Germany.

For further information please visit https://www.academia-gruppe.de/.

About CERTANIA

For further information please visit https://certania.com/de/.

Relibell joins CERTANIA

The expert in certification of renewable energy plants joins CERTANIA group.

Munich/Erfurt, April 9, 2024. Relibell has partnered with CERTANIA, a growing group specializing in Testing, Inspection, and Certification services. This strategic move allows Relibell, a leading provider for compliance certification of plants for renewable energy such as wind, photovoltaic (PV), biogas and hydropower, to accelerate growth.

Established in 2020 and headquartered in Erfurt, Germany, Relibell has emerged as an expert and trusted partner serving operators, builders, planners, and suppliers of renewable energy plants with compliance certification before being connected to the grid. Relibell currently issues plant certification type A, B, & C, as well as EZA declarations of conformity.

Joining CERTANIA marks a significant milestone for Relibell, opening doors to broaden its compliance services to renewable power plants. This partnership enhances the company’s ability to provide safety, quality, and regulatory compliance services for renewable energy plants.

Under the leadership of Managing Director Tobias Walter, the Relibell management team retains independence while accessing the resources of the larger group, facilitating continued growth and service expansion. Says Tobias Walter about the strategic move: „With the joint expertise and the collaboration with other CERTANIA partner companies, we will be able to support more customers in this fast-growing market segment. Being part of CERTANIA enables us to further invest in our service portfolio and infrastructure, providing innovative knowledge management tools. “

Relibell’s offering of certification services for the electrical power sector including photovoltaics, wind, biogas and hydro perfectly fits into CERTANIA’s certification and verification segment.

Moritz Gruber, CEO and managing shareholder of CERTANIA, welcomes Relibell and extends the invitation to join this unique group to other entrepreneurs and owners of companies in the field of scientific, laboratory, and compliance services: “We provide an opportunity to put their company into a future-proof structure. It is our fundamental aim to build a group for the long run, where strong partner companies flourish, while retaining their identity. With the addition of Relibell, we can now serve the renewable energy market, supporting Germany’s ambitious sustainable energy goal of 80% by 2030”.

About Relibell:

Relibell Zertifizierungsgesellschaft mbH, established in 2020 and based in Erfurt, Germany, is a leading service provider specialized in certifying renewable energy plants such as wind, photovoltaic (PV), biogas, and hydropower. We issue compliance certificates for operators, builders, planners, and suppliers. Our core competencies include issuing plant certification types A, B, and C, and EZA declarations of conformity. Accredited by DAkkS according to DIN EN ISO/IEC 17065, we’re committed to environmental responsibility. For more information, visit relibell.de

About CERTANIA: